205 participants
UNcovering the Difference Between Ranibizumab and Aflibercept, Focusing on Systemic Anti-vascular Endothelial Growth Factor (VEGF) Effects in Patients With neovascuLar Age-related Macular Degeneration (AMD)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2017-05-03
- Start Date:
- 2014-04-30
- Completion:
- 2015-09-30
Conditions
- Neovacular Age-related Macular Degeneration
Interventions
- PROCEDURE